PlainRecalls
FDA Devices Moderate Class II Ongoing

Tina-quant D-Dimer Test System, Fibrinogen/Fibrin Degradation Products Assay, Material Numbers 03001245322 - (cobas c 311, 501 and 502; INTEGRA 400 plus), 08105618190 - (cobas c 303 and 503)

Reported: November 29, 2023 Initiated: October 3, 2023 #Z-0352-2024

Product Description

Tina-quant D-Dimer Test System, Fibrinogen/Fibrin Degradation Products Assay, Material Numbers 03001245322 - (cobas c 311, 501 and 502; INTEGRA 400 plus), 08105618190 - (cobas c 303 and 503)

Reason for Recall

Elevated results were detected with Li-heparin plasma samples when compared to citrated plasma samples.

Details

Units Affected
5,263 kits
Distribution
US Nationwide distribution.
Location
Indianapolis, IN

Frequently Asked Questions

What product was recalled?
Tina-quant D-Dimer Test System, Fibrinogen/Fibrin Degradation Products Assay, Material Numbers 03001245322 - (cobas c 311, 501 and 502; INTEGRA 400 plus), 08105618190 - (cobas c 303 and 503). Recalled by Roche Diagnostics Operations, Inc.. Units affected: 5,263 kits.
Why was this product recalled?
Elevated results were detected with Li-heparin plasma samples when compared to citrated plasma samples.
Which agency issued this recall?
This recall was issued by the FDA Devices on November 29, 2023. Severity: Moderate. Recall number: Z-0352-2024.